A new paper provides timely evidence to explain the therapeutic benefits of vagal nerve stimulation(VNS), a nervous system-modifying treatment that proponents say could offer relief to patients with lupus, arthritis and even heart failure.
Its a prospect that sounds too good to be true. One 20-minute outpatient surgery could lead to relief from epilepsy, depression, arthritis, heart failure and lupus. Thats the ultimate promise of VNSn, a technique that has accrued interest from enthusiastic startups and major biopharma firms alike.
Importantly, it has also accrued some convincing evidence to back up at least some of its claims VNS has been approved by the FDA as a therapy for treatment-resistant depression and epilepsy. As of 2015, 100,000 people worldwide had received a VNS implant.
But large gaps remain in our understanding of how VNS works. One of those gaps has now been plugged with the publication of a paper investigating how a technique called anodal block works to allow targeted stimulation during VNS. The research team behind the paper, led by Dr Stavros Zanos, have published their work in Scientific Reports.
VNS involves implanting electrodes on the vagal nerve near the carotid artery in the neck. The vagal nerve is in charge of routing signals between the brain and the peripheral organs. As Zanos, an assistant professor in the Institute of Bioelectronic Medicine at the Feinstein Institutes for Medical Research, explains, this means it is a uniquely attractive target for neurotechnology. This is primarily the nerve that the brain uses to convey information to the organs and change the way they function. And also, it's the main nerve through which information about the function of the organs is conveyed back into the brain. Because it's such an important nerve for ongoing physiology, it's a very attractive target for neuromodulation, says Zanos.
During VNS implantation, a pair of electrodes is attached to the vagus nerve. Depending on the electrode polarity, signals to or from the brain are stimulated or blocked when the VNS device is activated.
But the nervous system is a little more complicated than a two-lane highway. Nerve fibers sending signals in different directions exist within these larger bundles. Getting the level of stimulation right to ensure therapeutic benefit is of central importance, but is currently done quite crudely, Zanos tells me: The way VNS is done clinically is by increasing intensity. The healthcare provider changes some parameters, most notably the intensity, until the patient starts getting some side effects. Typically, those side effects have to do with contraction of the laryngeal muscles, so it causes coughing, and voice hoarseness.
This is far from optimal, and Zanos says that fine-tuning the approach is a priority. If we wanted to deliver an individualized therapy, we would have to know exactly how we're affecting the physiology of a specific individual, he says.
Anodal block is a central tenet of the current surgical procedure. The precise placement of the VNS electrodes can limit nerve conduction in the fibers under the positively charged anode back in the simplified highway example, this is the equivalent of setting up a tollbooth for traffic going in one direction the flow is slowed, if not stopped. But evidence that anodal block works this way in practice was sorely lacking from the wider literature. Would it be possible to find a biomarker, Zanos wondered, that could show that anodal block works as intended?Zanos and his team investigated this possibility by carrying out experiments with rats. Firstly, they needed to see what would happen when electrical impulses up and down the vagus highway were stopped entirely. The rodents had VNS devices implanted, and then had their vagus nerve cut either above or below the implant completely ending any vagus electrical stimulation towards the brain or the peripheral organs, respectively.
Zanos team noticed a consistent marker. Rats with intact vagus nerves showed a heavy reduction in their breathing and heart rates. When the same rats had their vagus nerve severed near the brain, the rats breathing rates returned to normal whilst the heart rate remained low. Severing the nerve nearer to the body had the opposite effect.
This told Zanos team that:
With these easy-to-measure markers identified, the next step was to work out whether breathing and heart rate were consistently affected by anodal block.The theories behind anodal block suggested that if the anode polarity was towards the brain, then the VNS devices effects on breathing rate would be reduced. Anode polarity facing the body would impair the effects on heart rate.
Whilst the same drastic changes seen in the first experiment were not present the rats in this group had intact vagus nerves, so signals still traveled both ways Zanos noted that their results supported the theories around anode block in a large number of the rats studied.
Importantly, these results werent consistent across all the rats studied. Three rats actually showed reversed effects. This paradox, says Zanos, is likely to be explained by the stimulation of the nearby aortic depressor nerve by the VNS. This unintended stimulation hasnt proved an issue in human VNS studies, so is likely to be a quirk only seen in certain rodents.
Even if the inconsistent data has an explanation, the study still highlights that the mechanisms behind VNS would be much easier to understand if those individual types of nerve fiber could be better identified. Zanos says this will be the target of an upcoming paper that should advance understanding in the area further. In the upcoming paper, says Stavros, We look at even finer relationships between some of these biomarkers; heart rate, breathing rate, but also additional biomarkers with the activation of specific fiber types.
Zanos suggests his teams data supports the idea that anodal block can make VNS more directional and targeted. But there is obviously more research to be done to support our understanding of why VNS works. This, says Zanos, could lead to the technique meeting its potential sooner than we might think. He highlights two US-based companies, LivaNova and Set Point Medical, who are investigating VNS for heart failure and rheumatoid arthritis respectively. My guess is that in the next two or three years at least one of these [companies], based on what I what I see in preliminary reports, will be successful, and VNS will be part of the therapeutic options for physicians for these two diseases.
Read more:
- Systems-Based Neurotechnology for Emerging Therapies (SUBNETS) - December 8th, 2016 [December 8th, 2016]
- Backing British innovation: Royal Academy of Engineering launches ... - Elite Business Magazine - February 13th, 2017 [February 13th, 2017]
- Global Fingerprint Biometrics in the VAR Market 2016 Fulcrum Biometrics, Neurotechnology, 360 Biometrics ... - Albanian Times - February 16th, 2017 [February 16th, 2017]
- Israel and Indiana: Why You're Getting an Invitation to the Holy Land ... - 93.1 WIBC Indianapolis - February 22nd, 2017 [February 22nd, 2017]
- 5th Annual Big Idea Competition Nets Three Winners Colorado ... - Colorado College News - February 23rd, 2017 [February 23rd, 2017]
- 3Q: US Patent Office's Ruling on CRISPR - Bioscience Technology - February 24th, 2017 [February 24th, 2017]
- 7 reasons you must attend WIRED Health 2017 - Wired.co.uk - February 24th, 2017 [February 24th, 2017]
- Edward Boyden - Big Think - February 25th, 2017 [February 25th, 2017]
- What Health Care Can Learn from Wal-Mart - Wall Street Journal (subscription) (blog) - March 4th, 2017 [March 4th, 2017]
- A report released today by RBC Capital Markets about Stryker Corporation (NYSE:SYK) ups the target price to $135.00 - Breaking Finance News - March 4th, 2017 [March 4th, 2017]
- Paralysis patients achieve fastest typing yet with new brain-computer interface - The Brown Daily Herald - March 7th, 2017 [March 7th, 2017]
- How 'brain wearables' can address 21st century needs - IoT Tech News - March 7th, 2017 [March 7th, 2017]
- Stryker's AVAflex Vertebral Balloon System Receives FDA 510(k ... - OrthoSpineNews - March 8th, 2017 [March 8th, 2017]
- Stryker's Spine Division To Feature Novel 3D-Printed Spinal Implants at AAOS Conference - OrthoSpineNews - March 9th, 2017 [March 9th, 2017]
- Stryker's Spine division to exhibit key technologies at AAOS 2017 - Yahoo Finance - March 9th, 2017 [March 9th, 2017]
- Stryker Corporation named one of Fortune Magazine's 100 Best Companies to Work For for seventh consecutive year - Yahoo Finance - March 9th, 2017 [March 9th, 2017]
- How to ensure future brain technologies will help and not harm society - USAPP American Politics and Policy (blog) - March 10th, 2017 [March 10th, 2017]
- Preview: MedX Future of Healthcare conference - The Mancunion - March 11th, 2017 [March 11th, 2017]
- Stryker's Spine division to exhibit key technologies at AAOS 2017 - OrthoSpineNews - March 11th, 2017 [March 11th, 2017]
- Elon Musk Wants to Merge Man and MachineHere's What He'll ... - Observer - April 8th, 2017 [April 8th, 2017]
- Synchron Inc. Secures $10 Million in Series A Financing Round - PR Newswire (press release) - April 8th, 2017 [April 8th, 2017]
- How Neurotechnology Is Helping The San Francisco Giants Train Better - PSFK (subscription) - April 8th, 2017 [April 8th, 2017]
- Positive Media Coverage Very Likely to Affect Stryker (SYK) Share Price - Chaffey Breeze - June 6th, 2017 [June 6th, 2017]
- Shoosmiths advises PD Neurotechnology on 1.34m investment - Scottish Legal News - June 6th, 2017 [June 6th, 2017]
- Shoosmiths advises PD Neurotechnology on 1.34m (EUR) investment - Shoosmiths legal updates (press release) - June 7th, 2017 [June 7th, 2017]
- Comparing Accuray (ARAY) & Stryker (SYK) - The Cerbat Gem - June 9th, 2017 [June 9th, 2017]
- Welch Capital Partners Increased By $3.59 Million Its Eqt (EQT) Position, Stryker (SYK) Sellers Decreased By 3.59 ... - UtahHerald.com - June 10th, 2017 [June 10th, 2017]
- Head to Head Analysis: Accuray (ARAY) and Stryker Corporation (SYK) - Sports Perspectives - June 13th, 2017 [June 13th, 2017]
- Neurotechnology Announces MegaMatcher Accelerator Extreme ... - findBIOMETRICS - June 13th, 2017 [June 13th, 2017]
- Comparing Stryker Corporation (SYK) & Accuray (ARAY) - Markets Daily - June 14th, 2017 [June 14th, 2017]
- Neurotechnology Releases MegaMatcher Accelerator Extreme, the Fastest Biometric Engine in the World - PR Newswire (press release) - June 14th, 2017 [June 14th, 2017]
- Neurotech panel shares successes from first year - Cornell Chronicle - June 14th, 2017 [June 14th, 2017]
- Neurotechnology Researchers Win Kaggle Competition with Deep Neural Network Solution for The Nature ... - PR Newswire (press release) - June 14th, 2017 [June 14th, 2017]
- Neurotechnology Wins Fisheries-Focused Computer Vision Competition - findBIOMETRICS - June 14th, 2017 [June 14th, 2017]
- Helping or Hacking? Engineers, Ethicists Must Work Together on Brain-Computer Interface Technology - Government Technology - June 16th, 2017 [June 16th, 2017]
- Accuray (ARAY) versus Stryker Corporation (SYK) Head-To-Head Review - The Cerbat Gem - June 17th, 2017 [June 17th, 2017]
- The Funded: Justin Kan's latest startup gets backing from more than 100 investors - Silicon Valley Business Journal - June 17th, 2017 [June 17th, 2017]
- New SentiVeillance Server from Neurotechnology Adds Face Recognition and Analytics to Video Management Systems - PR Newswire (press release) - June 20th, 2017 [June 20th, 2017]
- Neurotechnology Announces SentiVeillance Server Facial Recognition Solution - findBIOMETRICS - June 20th, 2017 [June 20th, 2017]
- SentiVeillance Server - Face Recognition and Analytics to Video Management Systems - Officer.com (press release) (registration) (blog) - June 21st, 2017 [June 21st, 2017]
- Neurotechnology Announces MegaMatcher 10 - findBIOMETRICS - June 21st, 2017 [June 21st, 2017]
- Neurotechnology adds face recognition, tracking to video surveillance systems; researchers win competition - Biometric Update - June 22nd, 2017 [June 22nd, 2017]
- Neurotechnology makes a number of updates to the MegaMatcher product line - Biometric Update - June 23rd, 2017 [June 23rd, 2017]
- Neurotechnology Develops 3D Printing Method with Non-Contact Ultrasonic Manipulation Technology - 3DPrint.com - June 26th, 2017 [June 26th, 2017]
- Mind-blowing ultrasonic 'printer' uses lasers and high-frequency sound to assemble electronics - Digital Trends - June 29th, 2017 [June 29th, 2017]
- HIRREM Neurotechnology Better Than Placebo for Insomnia - Sleep Review - July 10th, 2017 [July 10th, 2017]
- DARPA invests further in neurotechnology - SD Times - SDTimes.com - July 14th, 2017 [July 14th, 2017]
- Infinitely Flexible 3D Printing with Ultrasonic Manipulation? - ENGINEERING.com - July 15th, 2017 [July 15th, 2017]
- Insider Activity Stryker Corporation (NYSE:SYK) - Highlight Press - July 16th, 2017 [July 16th, 2017]
- Comparing Uroplasty (UPI) and Stryker Corporation (NYSE:SYK) - The Cerbat Gem - July 17th, 2017 [July 17th, 2017]
- Biomimetic Underwater Robot Program - July 17th, 2017 [July 17th, 2017]
- Preserving the Right to Cognitive Liberty - Scientific American - July 18th, 2017 [July 18th, 2017]
- BRAIN center gathers to ponder future, direction - Arizona State University - July 20th, 2017 [July 20th, 2017]
- Stryker Expands Its Interventional Spine Segment - Market Realist - July 22nd, 2017 [July 22nd, 2017]
- Trivascular Technologies (TRIV) & Stryker Corporation (SYK) Critical Review - Stock Observer - July 26th, 2017 [July 26th, 2017]
- Arshya Vahabzadeh: Innovating at the Intersection of Brain ... - HuffPost - July 27th, 2017 [July 27th, 2017]
- fMRI and EEG May Be Able to Reveal Consciousness in Comatose Patients - Physical Therapy Products - July 29th, 2017 [July 29th, 2017]
- Stryker reports 6.1% Q2 growth, installs 26 Mako systems: 7 things to know - Becker's Orthopedic & Spine - July 29th, 2017 [July 29th, 2017]
- Tufts Hosts Engineering Conference - Tufts Now - July 29th, 2017 [July 29th, 2017]
- Stryker Corporation (NYSE:SYK) and Uroplasty (UPI) Financial Survey - Stock Observer - July 29th, 2017 [July 29th, 2017]
- Elon Musk speaks of being 'bipolar' on Twitter - Mashable - July 31st, 2017 [July 31st, 2017]
- Team Neurotechnology Innovations Translator - July 31st, 2017 [July 31st, 2017]
- Elon Musk opens up about the highs and lows of his life on Twitter - Firstpost - August 1st, 2017 [August 1st, 2017]
- Train your brain at Ky learning centre - Shepparton News - August 2nd, 2017 [August 2nd, 2017]
- Stryker Exceeded Analysts' Sales Estimates in 2Q17 - Market Realist - August 2nd, 2017 [August 2nd, 2017]
- $2.6 million to build versatile genetic toolkit for studying animal ... - Washington University in St. Louis Newsroom - August 3rd, 2017 [August 3rd, 2017]
- National Science Foundation $9M grant will fund neurotech research hub at Cornell - The Ithaca Voice - August 3rd, 2017 [August 3rd, 2017]
- NSF awards Cornell $9M grant for neurotech research hub - The Central New York Business Journal - August 4th, 2017 [August 4th, 2017]
- NSF issues awards to advance a national research infrastructure for neuroscience - National Science Foundation (press release) - August 4th, 2017 [August 4th, 2017]
- $9M Grant Will Create Neurotech Research Hub - Lansing Star - August 4th, 2017 [August 4th, 2017]
- NSF backs photonics-enabled neuroscience networks - Optics.org - August 9th, 2017 [August 9th, 2017]
- Washington University awarded $2.6 million for neurotechnology research - St. Louis Business Journal - August 9th, 2017 [August 9th, 2017]
- fMRI, EEG may detect consciousness in TBI patients - Medical Physics Web (subscription) - August 10th, 2017 [August 10th, 2017]
- Financial Analysis: Stryker Corporation (NYSE:SYK) vs. Uroplasty (UPI) - The Cerbat Gem - August 12th, 2017 [August 12th, 2017]
- In the Future, Humans Will Use Brain to Brain Communication and Download Their Memories If Elon Musk Has His Way - Newsweek - August 13th, 2017 [August 13th, 2017]
- How Elon Musk Plans to Turn Humans Into Robots - Yahoo News - August 14th, 2017 [August 14th, 2017]
- Critical Comparison: Stryker Corporation (SYK) versus Glaukos Corporation (GKOS) - TrueBlueTribune - August 21st, 2017 [August 21st, 2017]
- Early career scientists named Mong Fellows in Cornell Neurotech - Cornell Chronicle - August 21st, 2017 [August 21st, 2017]
- Could this back-pain device end need for opioids? - The Columbus Dispatch - August 21st, 2017 [August 21st, 2017]
- New technologies to diagnose and treat neurological diseases - Medical Xpress - August 22nd, 2017 [August 22nd, 2017]